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p21Cip1 plays a critical role in the 
physiological adaptation to fasting 
through activation of PPARα
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Fasting is a physiological stress that elicits well-known metabolic adaptations, however, little is 
known about the role of stress-responsive tumor suppressors in fasting. Here, we have examined the 
expression of several tumor suppressors upon fasting in mice. Interestingly, p21 mRNA is uniquely 
induced in all the tissues tested, particularly in liver and muscle (>10 fold), and this upregulation is 
independent of p53. Remarkably, in contrast to wild-type mice, p21-null mice become severely morbid 
after prolonged fasting. The defective adaptation to fasting of p21-null mice is associated to elevated 
energy expenditure, accelerated depletion of fat stores, and premature activation of protein catabolism 
in the muscle. Analysis of the liver transcriptome and cell-based assays revealed that the absence of p21 
partially impairs the transcriptional program of PPARα, a key regulator of fasting metabolism. Finally, 
treatment of p21-null mice with a PPARα agonist substantially protects them from their accelerated 
loss of fat upon fasting. We conclude that p21 plays a relevant role in fasting adaptation through the 
positive regulation of PPARα.
Fasting has been thoroughly studied regarding the metabolic adaptations that it triggers. These adaptions basi-
cally consist in the sequential mobilization of internal nutrient stores, starting with hepatic glycogen, then triglyc-
erides from the adipose tissue, and finally proteins from muscle1. However, the implications of fasting adaptation 
go further beyond metabolism. For example, fasting strongly diminishes the toxic effects of chemotherapy on 
normal cells and tissues, both in mice2 and humans3, and this has substantially increased the interest in under-
standing the link between stress responses and fasting.
Many tumor suppressors participate in stress signaling pathways, and this has been extensively studied in the 
context of cellular damage conducive to cancer, such as DNA damage and oncogenic stress4. However, the possi-
ble role of tumor suppressors in response to fasting has remained largely unexplored. Previous researchers have 
identified p21 (also known as p21Cip1 or CDKN1A) as a fasting-induced factor5, but nothing was known about the 
relevance and role of p21 in fasting adaptation.
The best understood functions of p21 are inhibition of the cyclin dependent kinases (primarily CDK2) and 
inhibition of the DNA replication processivity factor PCNA6, thereby efficiently blocking cell proliferation. In 
addition to this, p21 has a growing list of interacting partners including the binding and inhibition of transcrip-
tion factors, such as E2F1, STAT3 and MYC, all of them involved in cell proliferation and survival6. The levels of 
p21 are regulated transcriptionally by p53, as well as by important negative regulators of proliferation, such as 
TGFβ -activated SMAD complexes and FOXO proteins6.
In this work, we report that p21 is a critical factor for fasting adaptation and we present evidence for an 
unprecedented role of p21 as a positive regulator of PPARα , a key transcription factor that orchestrates multiple 
aspects of fasting adaptation, including fatty acid oxidation and ketogenesis7–9.
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Results
Characterization of fasting-induced p21 upregulation. Previous investigators have reported that p21 
mRNA is upregulated in many tissues upon fasting through a mechanism that is independent of p53 and partly 
mediated by FOXO15. We wanted to confirm and extend these findings and, for this, we began by analyzing 
whether other cell cycle inhibitors and tumor suppressors are also upregulated by fasting. Interestingly, only 
p21 mRNA was strongly induced upon fasting in the liver, while p16Ink4a, p19Arf, p27Kip1, or p53 mRNAs were 
unaffected (Fig. 1A). We found that this upregulation is present across all tissues tested (Fig. 1B), being more 
Figure 1. Characterization of fasting-induced p21 upregulation. (A) Relative mRNA expression of the 
indicated tumor suppressor genes in the liver after 48 h fasting compared to ad libitum fed mice (n = 4 per group, 
males, 12 weeks old). (B) Relative p21 mRNA levels in epididymal white adipose tissue (eWAT), brown adipose 
tissue (BAT), gastrocnemius, soleous, spleen and lung of mice after 48 h fasting or ad libitum feeding (same mice 
as in panel A). (C) Relative p21 mRNA levels in the indicated tissues of ad libitum fed and 48 h fasted wild type 
(WT) or p53KO mice (n = 4 per group, males, 12 weeks old). (D) Relative p21 and Pgc1α expression in the liver of 
ArfKO and Sirt1HET mice after 48 hours fasting or ad libitum feeding (n = 4 per group, males, 12 weeks old). The 
fasting-induced gene Pgc1α was used as control. (E) Relative p21 mRNA levels in HepG2 (human hepatocellular 
carcinoma) cells (left) or primary large-T immortalized mouse hepatocytes (right) cultured for 24 h in complete 
medium (DMEM + 10%FBS) or starvation medium (glucose-free and serum-free DMEM) and treated for 5 h 
with DMSO, 10 μ M CNIO PI3K inhibitor (PI3Ki) or 10 μ M forskolin (FSK). The experiment was performed 
twice with similar results and each time in three biological replicates. Data correspond to one experiment (n = 3). 
Levels of mRNA were normalized to β-actin, except for muscle that is normalized to Gapdh. Values correspond to 
average ± s.d. Statistical significance was determined by the unpaired two-tailed Student’s t test (panels A to D) or 
by two-way ANOVA and Bonferroni post-hoc test (panel E): *p < 0.05, **p < 0.01, ***p < 0.001.
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prominent in the liver and muscle. Also, fasting-induced p21 upregulation was independent of p53 (Fig. 1C) and 
p19Arf (Fig. 1D). The sirtuin SIRT1 is involved in many responses to nutrient deprivation10, but p21 upregulation 
by fasting was not affected in Sirt1-heterozygous mice (Fig. 1D).
The induction of p21 by nutrient deprivation was also recapitulated in cultured cells. In particular, we 
observed that p21 was significantly induced when human hepatocarcinoma HepG2 cells or mouse immortalized 
primary hepatocytes were starved (no serum and no glucose, for 24 h) (Fig. 1E). Nutrient deprivation, among 
many other effects, decreases PI3K activity and elevates cAMP, both being important for metabolic adaptation11. 
To explore the contribution of these pathways to the upregulation of p21, cells were treated with a pharmacologi-
cal inhibitor of PI3K or with forskolin (to increase cAMP levels). Interestingly, forskolin, but not PI3K inhibition, 
further enhanced the upregulation of p21 by nutrient deprivation in cells (Fig. 1E). These observations suggest 
that cAMP, possibly through the transcription factor CREB, is involved in the upregulation of p21 upon starva-
tion. Together, these observations reinforce the concept that p21Cip1 is induced by nutrient deprivation both at the 
organism level and in isolated cells.
Impaired adaptation to prolonged fasting in p21Cip1 deficient mice. To test the role of p21 in met-
abolic adaptation to fasting, p21-null (p21KO) mice were fasted for 48 h. We did not observe obvious differences 
after 24 h of fasting, which is consistent with a previous report5. Remarkably, at 48 h, p21KO mice presented 
important differences compared to their controls (WT). In particular, p21KO mice were extremely stressed or 
lethargic, although their weight loss was comparable to that of WT mice (Figure S1A). Upon necropsy, all WT 
mice still retained white adipose tissue (WAT) and interscapular brown adipose tissue (BAT) (Fig. 2A). In con-
trast, p21KO mice had remnants of WAT and BAT (Fig. 2A). Histologically, the size of p21KO adipocytes was 
dramatically reduced compared to controls (Fig. 2B). Mice deficient in p21 presented a remarkable drop in body 
temperature (rectal) upon 48 h of fasting (Fig. 2C).
A number of metabolic adaptations were significantly altered in fasted p21KO mice. In particular, serum free 
fatty acids (FFA), triglycerides (TG) and ketone bodies (KB) were much lower than in WT mice (Fig. 2D; Figure S1B; 
Table S1), which suggest that p21KO mice exhaust lipid stores prematurely compared to WT mice. The levels of 
IGF1, insulin and leptin were also significantly decreased in p21KO mice (Fig. 2D; Table S1). The above altera-
tions were accompanied by hepatic damage, as reflected by the serum levels of alanine aminotransferase (ALT) 
(Fig. 2D). Regarding the serum levels of amino acids, fasted p21KO mice presented higher levels of histidine, 
phenylalanine, tyrosine, leucine and valine (Fig. 2E). Interestingly, we also observed higher levels of expression 
of Murf1 in skeletal muscle, which encodes a key ubiquitin ligase for muscle protein degradation during fasting 
(Fig. 2F). We interpret that the enhanced muscle proteolytic activity of p21KO mice compensates their premature 
loss of lipid stores.
The above observations suggest that p21KO mice exhaust their energetic reserves prematurely during fasting. 
To directly evaluate this, we measured energy expenditure (EE) in WT and p21KO mice during 48 h of fasting 
(Fig. 3A). Notably, p21KO mice presented higher levels of EE during the total period of fasting, and particularly 
during the first dark and second light periods (Fig. 3A). No significant differences were observed in EE under 
normal feeding conditions (Figure S2A). Fasting induces behavioral changes that reflect in elevated locomotor 
activity12. Interestingly, p21KO mice showed a significant increase in activity during the entire period of fasting 
(Fig. 3B), while no differences were observed under feeding conditions (Figure S2B). Together, we conclude that 
in the absence of p21, mice do not adapt efficiently to energy deprivation and exhaust prematurely their nutrient 
stores.
Global transcription changes in p21Cip1 deficient mice. To gain insight into the mechanisms responsi-
ble for the defective adaptation of p21KO mice to prolonged fasting, we obtained the liver RNAseq profiles of WT 
and p21KO mice under standard feeding conditions and after 24 h of fasting (n = 2–3 per group). We chose 24 h 
of fasting to capture early defects in p21KO mice, prior to the severe phenotypes observed at 48 h. A total of 451 
genes (128 UP and 323 DOWN) were differentially expressed (FDR q < 0.05) between p21KO and WT livers after 
24 h of fasting and 96 of these genes (8 UP and 88 DOWN) were already differentially expressed under ad libitum 
feeding (Fig. 4A; Table S2). Gene-set enrichment analysis (GSEA) of pathways (KEGG) indicated an abundance 
of downregulated pathways related to inflammation in fasted p21KO livers (Fig. 4B,C; Table S3). One of the major 
consequences of fasting and dietary restriction is a general decrease in the number of infiltrating leukocytes and 
markers of inflammation13–15. To directly measure this, we quantified leukocyte (CD45+ cells) infiltration in the 
liver and we observed a significant reduction in fasted p21KO livers compared to fasted WT controls (Fig. 4D). 
This was further substantiated by measuring the mRNA levels of genes related to the immune system (Figure 
S3A), and by staining liver infiltrating macrophages with F4/80 (Fig. 4E). Of note, the relative proportion of 
leukocyte sub-populations was not altered in p21KO livers relative to WT controls (Figure S3B). We interpret 
that the reduced inflammation observed in p21KO mice further reflects the aggravated consequences of fasting 
in these mice.
Decreased PPARα activity in the liver of p21Cip1 deficient mice. We took note of the fact that “PPAR 
signaling” was one of the gene sets downregulated in fasted p21KO mice compared to WT mice (Fig. 4B). PPARα 
is a critical hepatic transcription factor activated in response to nutrient deprivation and required for fasting adap-
tation16,17. Indeed, GSEA using a PPARα signature18 further suggested a reduction in PPARα activity (Fig. 5A). 
To validate the RNAseq data, we measured directly the mRNA levels of well-established PPARα transcriptional 
targets. Interestingly, some PPARα targets were significantly downregulated in fasted p21KO livers compared to 
WT controls (Fig. 5B). A similar situation was observed in immortalized primary hepatocytes upon nutrient star-
vation (Fig. 5C). Moreover, after 48 h of serum and glucose starvation, cultures of immortalized p21KO primary 
hepatocytes underwent massive cell death, whereas WT control hepatocytes remained largely viable (Fig. 5D).
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Figure 2. Impaired adaptation to prolonged fasting in p21Cip1 deficient mice. (A) Representative pictures 
of epididymal white adipose tissue (eWAT) and interscapular brown adipose tissue (BAT) of wild type and 
p21KO mice after 48 h fasting. (B) Representative pictures of H&E-stained sections of eWAT and BAT of ad 
libitum-fed or 48 h fasted WT and p21KO mice. Bars correspond to 0.2 mm. Bars in high magnification insets 
correspond to 50 μ m. (C) Temperature of fed and 48 h fasted WT and p21KO mice. Temperature was measured 
with a rectal thermometer (n = 4–6 males, 12 weeks old). (D) Glucose (GLUC.), free fatty acids (FFA), ketone 
bodies (KB), tryglicerides (TG), insulin, IGF1, leptin and alanine aminotransferase (ALT) serum levels in WT 
and p21KO mice after 48 hours fasting or ad libitum feeding. (E) Relative level of the indicated amino acids in 
the serum of WT and p21KO mice after ad libitum feeding, 24 h or 48 h fasting. Measurements were performed 
by NMR (n = 4–5 males, 12 weeks old). (F) Relative expression of the indicated proteolytic factors in muscle 
of WT and p21KO mice after ad libitum feeding or 48 h fasting (n = 3 males, 12 weeks old). Values correspond 
to mean ± s.d. Statistical significance was determined by two-way ANOVA and Bonferroni post-hoc test: 
*p < 0.05, **p < 0.01, ***p < 0.001. See also Figure S1.
www.nature.com/scientificreports/
5Scientific RepoRts | 6:34542 | DOI: 10.1038/srep34542
To directly address the impact of p21 on the functionality of PPARα , we used the PPARα agonist WY-14,643. 
Interestingly, the induction of some WY-14,643-responsive genes was impaired in the absence of p21, both in pri-
mary hepatocytes (Fig. 5E) and in overnight fasted mice (Fig. 5F). We wondered if the observed partial activation 
of PPARα by WY-14,643 in p21KO mice would be sufficient to normalize their fasting response. Remarkably, 
p21KO mice treated with WY-14,643 were protected from severe fat depletion (Fig. 5G) and serum FFA depletion 
(Figure S4) after 48 h fasting. We conclude that p21 contributes to the metabolic adaptation to fasting acting in 
part as a positive regulator of PPARα.
Discussion
Here, we have addressed a general question regarding the involvement of tumor suppressors in the response to 
fasting. On one hand, fasting is a physiological stress that triggers complex metabolic adaptions. On the other 
hand, some of the most important tumor suppressors participate in stress signaling pathways that are activated to 
prevent proliferation under stressful conditions. To explore the possible role of tumor suppressors in fasting, we 
began by asking if their mRNA levels respond to fasting. Interestingly, p21, but not other tested tumor suppressors 
tested, was highly upregulated in multiple tissues upon fasting and independently of p53.
Of note, p21-null (p21KO) mice manifested profound defects in the adaptation to fasting. This was particu-
larly evident after 48 h of fasting, when p21KO mice showed clear signs of energy exhaustion, including lower 
serum levels of triglycerides, free fatty acids, and ketone bodies, together with a dramatic reduction of IGF1 and 
leptin levels, and a significant reduction in body temperature. In addition, fasted p21KO mice presented elevated 
levels of amino acids in the serum and a significant upregulation of the ubiquitin ligase MURF1 implicated in the 
degradation of muscle proteins. Finally, we observed that p21KO mice had higher energy expenditure during the 
first 36 h of fasting. All these alterations are consistent with a premature exhaustion of nutrient stores.
Unbiased examination of the transcriptome of p21KO livers upon 24 h fasting, when the severe defects of 
fasting have not been manifested yet, further supported the idea that the absence of p21 results in an accelerated 
onset of the effects of fasting. In particular, fasting reduces the levels of tissue infiltrating leukocytes present under 
normal feeding conditions13–15, but this reduction was more profound in the case of p21KO livers. This analysis 
also pointed out a defective activation of some PPARα transcriptional targets in fasted p21KO livers. This was 
particularly interesting because PPARα is critical for fasting adaptation16,17. In fact, PPARα -deficient mice present 
an abnormal response to fasting with some similarities to p21KO mice, such as lower body temperature and lower 
serum ketone bodies16,17. The defective activation of a subset of PAPRα transcriptional targets was confirmed in 
fasted p21KO livers, as well as, in p21KO hepatocytes upon nutrient starvation or treatment with a PPARα ago-
nist (WY-14,643). To test the role of defective PPARα in the misadaptation of p21KO mice to fasting, treatment of 
these mice with the PPARα agonist prevented their premature depletion of fat stores. We conclude that the tumor 
suppressor p21 contributes to fasting adaptation by acting as a positive regulator of PPARα .
Figure 3. Increased energy expenditure and activity in p21Cip1-deficient mice during fasting. (A) Left, 
energy expenditure (EE) of WT and p21KO mice during 48 h of fasting. Right, mean EE of WT and p21KO 
mice at the indicated periods (n = 8 male mice, 12 weeks old). (B) Left, activity of WT and p21KO mice during 
48 hours of fasting. Right, mean activity of WT and p21KO at the indicated periods under fasting conditions 
(same mice as in panel A). Values correspond to average ± s.e.m. Statistical significance was determined by the 
two-tailed Student’s t test: *p < 0.05, **p < 0.01. See also Figure S2.
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Figure 4. Global transcription changes in p21Cip1-deficient mice. (A) Differentially expressed genes (DEG) 
in the liver of p21KO compared to WT mice under ad libitum feeding conditions and upon 24 h fasting. Data 
were obtained from RNA-Seq analysis of 2–3 male mice per group. Red circles correspond to upregulated 
and green circles to downregulated genes. Values were considered significant when FDR value was q < 0.05. 
(B) Heat map of significantly altered pathways in the liver in the same samples as in panel A. Results were 
obtained from GSEA and considered significant when FDR < 0.25. (C) Representative GSEA plots of immune-
related pathways downregulated in fasted p21KO mice compared to fasted controls. FDR < 0.25. (D) Relative 
amount of CD45+ immune cells in the liver of ad libitum fed and 24 h fasted WT and p21KO mice. Values 
correspond to average ± s.d. (n = 6 males, 12–16 weeks old). (E) Representative pictures of F4/80 stained liver 
sections of WT and p21KO mice under feeding conditions, 24 h and 48 h fasting. Bars correspond to 50 μ m. 
Statistical significance was determined by two-way ANOVA and Bonferroni post-hoc test: **p < 0.01. See also 
Figure S3.
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Figure 5. Decreased PPARα activity in the liver of p21Cip1-deficient mice. (A) GSEA plot of the PPARα 
signature in the liver of 24 h fasted p21KO mice compared to control mice. FDR = 0.18. (B) Relative mRNA 
levels of PPARα target genes in the liver of WT and p21KO mice under ad libitum feeding conditions and 
upon 24 h fasting (n = 6 per group, 12 weeks old male mice). (C) Relative mRNA levels of PPARα target genes 
expressed in WT and p21KO immortalized primary hepatocytes after culture in complete (DMEM + 10% FBS) 
or starvation medium (glucose-free and serum-free DMEM) for 24 h. The experiment was performed in 5–6 
biological replicates (n = 5–6). (D) Left panel, representative pictures of WT and p21KO large-T immortalized 
primary hepatocytes cultured for 48 h in complete medium (DMEM + 10% FBS) or starvation medium 
(glucose-free and serum-free DMEM). Right, representative pictures of WT and p21KO plates stained with 
crystal violet after 48 hours culturing in starvation medium. The experiment was repeated three times and 
each time in three biological replicates with similar results. (E) Relative expression of PPARα target genes in 
WT and p21KO immortalized primary hepatocytes cultured in complete medium and treated with DMSO or 
with 10 μ M of the PPARα agonist WY-14,643 for 24 h. The experiment was performed twice and each time in 
three biological replicates with similar results. One representative experiment is shown (n = 3). (F) Relative 
expression of PPARα target genes in the liver of WT and p21KO mice 6 h after treatment with vehicle or 75 mg/kg 
WY-14,643 by gavage. Mice were previously fasted overnight and maintained without food during the 
experiment. (G) Representative fields of epididymal white adipose tissue of WT and p21KO mice treated with 
vehicle or 75 mg/kg WY-14,643 by gavage (4 treatments, see Methods) during a period of 48 h fasting (n = 3–4 
per group, 14 weeks old male mice). Bars correspond to 30 μ m. Levels of mRNA were normalized to β-actin. 
Values correspond to average ± s.d. Statistical significance was determined by two-way ANOVA and Bonferroni 
post-hoc test: *p < 0.05, **p < 0.01, ***p < 0.001. Only significant differences between WT and p21KO samples 
under the corresponding experimental conditions (fasting, WY-14,643) are shown. See also Figure S4.
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Methods
Ethics statement. All animal procedures were approved by the CNIO-ISCIII Ethics Committee for 
Research and Animal Welfare (CEIyBA) and the Community of Madrid, and conducted in accordance to the 
recommendations of the Federation of European Laboratory Animal Science Associations (FELASA) and the 
institutional guidelines.
Mouse experimentation. Mice were housed under specific pathogen free (SPF) conditions, at 22 °C, and 
with 12 hours dark/light cycles (light cycle from 8 am to 8 pm). Mice were fed with standard chow diet (Harlan 
Teklad 2018, 18% of fat-based caloric content) or fasted for 48 or 24 hours, with ad libitum access to water, when 
specified. Complete necropsies were performed in parallel when ad libitum and fasted mice were compared. 
All the mice used in this work are C57BL6J/Ola.Hsd males of 10–16 weeks of age. Temperature was measured 
using a rectal thermometer (Braintree Scientific). For administration of WY-14,643, mice were fasted overnight, 
orally treated by gavage with 75 mg/kg WY-14,643 (Sigma) dissolved in PEG300 (Sigma) and 10% N-methyl-
2-pyrrolidone (Sigma) and sacrificed 6 hours later. When combined with 48 hours fasting, mice were treated four 
times with 75 mg/kg WY-14,643 by oral gavage (at the beginning of fasting and after 8, 24 and 32 hours of fasting).
Cells. Primary hepatocytes were obtained from the liver of 3–5 day-old neonates as previously described19 
and retrovirally immortalized with Large-T antigen (in vector pBABE-puro). Cells were maintained in complete 
medium consisting of DMEM supplemented with 10% fetal bovine serum (all by Gibco) and incubated in 20% O2 
and 5% CO2 at 37 °C. When indicated, cells were nutrient starved in starvation medium consisting of glucose-free 
DMEM (Gibco) without FBS supplementation for 24 or 48 hours and/or treated with 10 μ M forskolin (Sigma) for 
5 hours, 10 μ M CNIO PI3K inhibitor (PI3Ki)20 for 5 hours or the PPARα agonist WY-14643 (Sigma) for 24 hours. 
For crystal violet staining, cells were fixed in 1% glutaraldehyde for 10 minutes and stained with 0.1% crystal 
violet for 30 minutes.
Histology and immunohistochemistry. Tissues were fixed overnight in formalin, embedded in paraf-
fin blocks and sectioned. Tissue sections were stained with hematoxylin/eosin (H&E) or with anti-F4/80 (ABD 
Serotec, #MCA497) following standard procedures.
Indirect calorimetry and activity. Indirect calorimetry was performed following standard methods using 
Oxylet System metabolic chambers (Panlab Harvard Apparatus). Mice (12–13 weeks old males) were acclima-
tized to the measurement cages for  three days prior to data recording. Volume of consumed O2 (VO2) and elim-
inated CO2 (VCO2) was recorded in ad libitum fed mice for 48 hours. After that, food was withdrawn and data 
were recorded for the next 48 hours under fasting conditions with ad libitum water access. Room temperature 
was constantly kept at 21 °C and light/dark cycles were of 12 hours. Respiratory Quotient (RQ) was calculated 
as RQ = VCO2/VO2 from volumes of consumed O2 (VO2) and eliminated CO2 (VCO2) recorded every 24 min-
utes (8 simultaneous metabolic chambers). Energy Expenditure (EE) was calculated as EE = (3.815 + (1.232 × 
RQ)) × VO2 × 1.44). Moreover, we recorded mouse activity in time intervals of 20 minutes during the whole 
measurement period.
Serum analyses. For serum glucose determination, blood was collected from the tail tip and glucose 
was measured using Glucocard strips (A. Meranini Diagnosis). For serum isolation, blood was collected from 
post-mortem heart puncture. Serum insulin (Ultra Sensitive Mouse Insulin ELISA kit; Crystal Chem Inc.), 
Igf1 (Mouse/Rat IGF-1 ELISA; Demeditec), leptin (Crystal Chem Inc.) and adiponectin levels (Invitrogen) 
were measured by ELISA following the manufacturer’s instructions. Serum triglycerides (Serum Triglyceride 
Determination Kit; Sigma), free fatty acids (Wako NEFA C Kit; Wako Chemicals) and ketone bodies (Autokit 
3-HB; Wako Chemicals) were quantified by colorimetric assay. Alanine aminotransferase (ALT) levels were meas-
ured using the ABX PENTRA 400 clinical chemical analyser (Horiba ABX Diagnostics).
RNA analyses. Total RNA from tissues or cells was extracted using TRIZOL (Invitrogen). cDNA syn-
thesis was performed with 1–2 μg of RNA using iScript First Strand cDNA synthesis kit (BioRad #170-8891). 
Quantitative real time-PCR (qRT-PCR) was carried out using GoTaq Q-PCR Master Mix (Promega) in a 7500 Fast 
Real-Time PCR System (Applied Biosystems). Reactions were performed in triplicate and normalized by β-actin 
or Gapdh expression in the case of the muscle. Primer sequences are described in Supplementary Information 
(Table S4).
RNA-seq-based transcriptional profiling. Livers were snap-frozen in liquid nitrogen and RNA was pre-
pared using Trizol (Invitrogen) and RNeasy Mini kit (Qiagen) following the manufacturer’s instructions. RNA 
Integrity Number (RIN) was in the range of 9.1–9.5 (Agilent 2100 Bionalyzer). 2–8 ng of total RNA was used to 
synthesize the cDNA (SMARTer Ultra Low Input RNA Kit, version 3, Clontech #634848). After amplification 
with SeqAmp DNA Polymerase (Clontech), 10 ng of cDNA was used to prepare the adaptor-ligated library follow-
ing the “TruSeq DNA sample preparation guide” (part #15005180). The resulting cDNA libraries were sequenced 
for 50 bases in a single-read format (Illumina HiSeq2000). Reads were aligned to the mouse genome (GRCm38/
mm10) with TopHat-2.0.1021 using Bowtie 1.0.022 and Samtools 0.1.1923, allowing two mismatches and five mul-
tihits. Transcripts assembly, estimation of their abundances and differential expression were calculated with 
Cufflinks 2.2.121, using the mouse genome annotation data set RCm38/mm10 from the UCSC Genome Browser. 
Gene Set Enrichment Analysis (GSEA) was performed using annotations from the KEGG, Reactome and NCI 
databases. Genes were ranked using the t statistic. After Kolmogorov-Smirnoff correction for multiple testing, 
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only those pathways bearing a FDR < 0.25 were considered significant. Enrichment plots were also obtained with 
GSEA and ranked according to their enrichment score (ES).
Flow cytometry. Cells from ad libitum fed or 24 hour fasted WT and p21KO mice (12–16 weeks old, n = 6) 
were isolated from spleen and liver by disaggregating tissues through a 70 μ m or 100 μ m strainer respectively. 
Following erythrocyte lysis by Red Blood Cell Lysis Buffer (Qiagen), immune cells from the liver were further 
isolated using a 38–70% Percoll gradient (GE Healthcare). Cells were then blocked in Fc block (CD16/CD32, BD 
Biosciences #553141) diluted 1:400 on ice for 30 minutes and incubated with the following conjugated antibodies for 
1 hour at 4 °C in a rotating platform: CD8a-FITC (eBioscience #11-0081-82), CD4-PE (eBioscience #12-0041-82), 
CD45-PerCP (Biolegend #103130), CD11b-PerCP/Cy5.5 (eBioscience #45-0112-82), Gr1-PECy7 (eBioscience 
#25-5931-82), NK1.1-PECy5 (Biolegend #108715), F4/80-AF647 (eBioscience #12-0041-82), CD3-AF700 (eBiosci-
ence #56-0032-82), CD19-APC/EF780 (eBioscience #47-0193-80) and B220-APC/EF780 (eBioscience #47-0452-
82). Splenocytes were used as Fluorescence Minus One (FMO) to gate cell populations and commercial anti-mouse 
or anti-rat IgG beads (BD Biosciences #552843 or #552844) to compensate for fluorochrome spectral overlap. We 
used pulse processing to exclude cell aggregates and an amine reactive live/dead dye (Aqua, Invitrogen) to exclude 
dead cells. At least 10,000 cells from the CD45 gate were collected. Cells were analyzed in an LSR-Fortessa (BD 
Biosciences; FACS Diva software) and all data analyzed using FlowJo v9.6.2 software (Trestar, Oregon).
Nuclear magnetic resonance. Mice blood for serum isolation was collected by post-mortem heart punc-
ture. After coagulation in ice, 100 μ l of serum were mixed with 100 μ l ice-cold 2X PBS buffer in deuterium oxide 
(D2O), centrifuged for 10 min at 16000 × g and transferred to a 3 mm NMR sample tube. NMR spectra were 
recorded at 20 °C in 9 mins on a Bruker Avance 700 MHz spectrometer. Metabolite levels in serum samples were 
determined from the integrals of the most resolved and largest signals of each metabolite (for example methyl 
groups of lactate, alanine and pyruvate, and H4 proton of glucose) in 1D 1H NMR spectra acquired with a trans-
versal relaxation filter (CPMG of 200 ms, τ = 0.4 ms) that attenuates the fast relaxing signals of macromolecules 
(proteins, lipids and lipoproteins) signals and optimises the NMR signals of low mass metabolites for their quan-
tification24. Thus, the obtained values of integrals are not absolute concentrations but relative concentrations in 
arbitrary units (AU).
Statistical analyses. Values are expressed as mean ± s.d. (the only exception is the calorimetry and activ-
ity data, Figs 3 and S2, where values correspond to the mean ± s.e.m.). Comparisons between two groups or 
conditions (Figs 1A–D and 3) were performed using unpaired two-tailed Student’s t-test. All the other analy-
ses correspond to multiple comparisons and were performed using two-way ANOVA and Bonferroni post-hoc 
test. Differences with P values of < 0.05 were considered to be statistically significant (*p < 0.05, **p < 0.01, 
***p < 0.001). Statistical analyses were performed using Excel or GraphPad Prism software.
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